Über uns

Novel research illuminates breast milk’s unique contribution to COVID-19 defense in infants

Real-world data on human milk-based fortification reveals limitations of protocol designs of two RCTs

Prolacta's human milk-based nutrition has touched the lives of 100,000 Premature and Critically Ill Infants Globally

Prolacta Bioscience recognizes advances in preterm care during NICU awareness month

Prolacta Bioscience applauds Ohio legislature for supporting Medicaid reimbursement for donor human milk-derived products

New study shows Prolacta’s human milk-based nutritional fortifiers save hospital NICUs up to $3.4M annually

Study reveals Prolacta’s 100% human milk-based nutritional fortifiers significantly increase bioactive proteins and antioxidant activity in human milk samples, outperforming cow milk-based fortifier

Prolacta Bioscience celebrates donor moms on World Human Milk Donation Day

Prolacta Bioscience recognizes contributions of breast milk donors during National Nutrition Month

The Prolacta Bioscience Foundation empowers parents and communities with over half a million dollars in grant funding in 2022

Hot Topics in Neonatology 2022 Conference will include symposium on benefits of vat pasteurization for human donor milk

Prolacta Clinical Advisory Board members present webinar on improved growth metrics for preterm infants fed an exclusive human milk diet

Prolacta Bioscience celebrates Prematurity Awareness Month and World Prematurity Day by recognizing the contributions of breast milk donors, parents of premature infants, and the NICU teams who care for them

New study finds improved long-term neurodevelopmental outcomes for extremely premature infants fed Prolacta’s exclusive human milk diet (EHMD)

Breaking data on the efficacy and cost-effectiveness of an exclusive human milk diet for premature infants to be presented at the American Academy of Pediatrics 2022 National Conference

New peer-reviewed study finds vat pasteurization retains molecular structure of naturally occurring bioactive proteins in human donor milk, similar to raw breast milk

Prolacta Bioscience recognizes nurses caring for fragile infants every day throughout Neonatal Nurses Week and NICU Awareness Month

Prolacta Bioscience celebrated Breastfeeding Awareness Month by recognizing the commitment of NICU parents to their infants’ health

Prolacta Bioscience Appoints Dr. Erin Hamilton Spence as Director of Clinical Education and Professional Development

Multiple peer-reviewed studies show Prolacta’s 100% human milk-based nutritional fortifiers reduce risk of life-threatening comorbidities in premature infants, compared to cow milk-based nutrition

Prolacta Bioscience introduces its first evidence-based feeding protocol for an exclusive human milk diet in the NICU

Prolacta Bioscience appoints David Steinberg as chief financial officer

International Conference on Human Milk Science & Innovation to discuss latest research on bioactivity and neurodevelopment

Alecia-Jane Twigger, Ph.D., wins the Ruth A. Lawrence Investigator Award for outstanding contributions to advancing human milk science

Independent, head-to-head study shows significant health benefits of early fortification associated with Prolacta Bioscience’s 100% human milk-based fortifiers compared to cow milk-based fortifiers for premature infants

Should human milk-based nutritional products for premature infants be homogenized? More research is needed, new journal article says

Prolacta Bioscience enrolls first infant in Japan-based clinical trial to evaluate the effect of an Exclusive Human Milk Diet on growth and safety in premature infants

Prolacta Bioscience Appoints Dr. Anne Beal to Board of Directors

Prolacta Bioscience Develops World’s First Test to Directly Detect Bacteria and Viruses, Including SARS-CoV-2, in Donor Breast Milk

Prolacta Bioscience Celebrates Prematurity Awareness Month by Recognizing Breast Milk Donors for Their Contributions to Premature Infants in the NICU

Mindy Fuzesy presents at Association of Women's Health, Obstetric and Neonatal Nurses 2021 virtual convention

Late-onset sepsis reduced in premature infants fed Prolacta’s 100% human milk-based fortifiers as part of an exclusive human milk diet

Prolacta Bioscience continues Advancing the Science of Human Milk, proud to partner with NICU teams in saving lives of premature infants

Association of Women’s Health, Obstetric, & Neonatal Nurses (AWHONN) encourages an exclusive human milk diet (EHMD) for vulnerable preterm infants in the neonatal intensive care unit (NICU)

Prolacta Bioscience hosts panel session on the need for uniform human milk safety standards at 2021 National Coalition for Infant Health Summit

Prolacta Bioscience supports Breastfeeding Awareness Month with donation of breast pumps to Alliance for Black NICU Families

Prolacta Bioscience congratulates Carolyn TenEyck, RN, on lifetime achievement award from National Black Nurses Association

Enrollment completed in clinical trial evaluating effect of exclusive human milk diet including a specialty fortifier in term infants born with single ventricle physiology

Four studies showed Prolacta Bioscience’s 100% human milk-based fortifiers reduced retinopathy of prematurity (ROP) in premature infants

Prolacta Bioscience provides update on latest SARS-CoV-2 data and continued safety of its human milk-based nutritional products

Research suggests some premature infants may go home from the NICU Up to 3 weeks earlier when fed Prolacta’s 100% human milk-based nutritional products; those with bronchopulmonary dysplasia may benefit the most

Prolacta Bioscience fortifiers reduce risk of serious lung disease and hospital costs among premature infants, compared to cow milk-based fortifiers

Multiple NICUs showed improved growth & lung health in premature infants by fortifying feeds safely in the first days of life with Prolacta’s 100% human milk-based fortifiers

The preemie parent’s survival guide to the NICU now reflects the latest clinical advancements to better support parents worldwide

Benefits of an exclusive human milk diet: conclusions, controversies, and a critical review of the evidence

Zeroing-in on efficacious human milk processing tech

Black, Hispanic, Asian babies born very early are less likely to receive lifesaving measures

Could human breast milk balance your gut microbiome?

Prolacta Bioscience begins testing its breast milk-based products for use in Japan

Human Milk Introduced to Japanese Market

Local mom helps premature babies by donating milk

The importance of data in an exclusive human milk diet: Key concepts and points of consideration

JFL becomes first US Virgin Islands hospital to adopt Prolacta protocol for extremely premature NICU babies

Nutrition and preterm infants

Dr Melinda Elliott of Prolacta Bioscience: 5 things we must do to improve the US healthcare system

Law requiring insurance to cover donated breastmilk gives preemies ‘best possible chance’

Understanding the nutritional needs of premature babies: A discussion with Dr. Melinda Elliott

Human breastmilk fortifiers may ward off eye disease in premature babies, finds Prolacta-backed study

Know your NICU nutrition: The importance of appropriate nutrition in the NICU

Dr. Melinda Elliott discusses the nutritional needs of premature infants in the NICU

Dr. Melinda Elliott discusses how nutrition can help bring preemies home sooner from the NICU

Banner - University Medicine Tucson Adopts Prolacta’s Exclusive Human Milk Diet